USD
Immune research peptides include chemically and biologically distinct materials. LL-37 is a 37-residue human cathelicidin, KPV is the Lys-Pro-Val tripeptide derived from the C-terminal region of alpha-melanocyte-stimulating hormone, and thymosin alpha-1 is a 28-residue peptide associated with immune regulation research.
- LL-37, KPV and thymosin alpha-1 differ in length and biological origin.
- Immune modulation can be context-dependent, not uniformly stimulatory or suppressive.
- Category membership does not establish approval or human efficacy.
Three immune peptide families
| Peptide | Identity | Common research focus |
|---|---|---|
| LL-37 | 37-residue human cathelicidin | Host defense, membrane interactions and immune signaling |
| KPV | Lys-Pro-Val tripeptide | Melanocortin-related inflammatory signaling models |
| Thymosin alpha-1 | 28-residue thymic peptide | Innate/adaptive immune regulation and tolerance pathways |
The word “immune” can suggest a single direction of effect, but immune signaling is context-dependent. LL-37 reviews describe both antimicrobial and immunomodulatory roles. KPV studies often focus on NF-kB-related inflammatory models. Thymosin alpha-1 literature examines several immune-cell pathways. These are separate lines of research.
How to evaluate an immune peptide claim
- Name the exact peptide and sequence length.
- Identify whether the evidence is biochemical, cellular, animal or clinical.
- State the tissue, cell type and endpoint.
- Check whether the material in the paper matches the catalog form.
- Report contradictory or context-dependent findings.
The Neural & Immune Research collection groups items for browsing, but it does not imply a shared mechanism. Use the NOVABIO product-name guide to expand abbreviations and preserve identity in records.
Why limitations belong in the article
Host-defense and immune-signaling peptides can act differently across concentration, tissue and model. A cell-culture result does not establish a safe or effective human use. Product descriptions should therefore avoid treatment claims and should link statements to the exact material and evidence layer.
If a product is not currently visible or a specification needs clarification, use NOVABIO Contact Us. Researchers can also browse Additional Research Products for non-peptide catalog supplies.
Frequently asked questions
What are immune research peptides?
Immune research peptides are peptides studied for interactions with innate or adaptive immune pathways. The category includes host-defense peptides, signaling fragments and thymic peptides. It does not mean that every member has the same sequence, receptor, direction of immune effect, regulatory status or level of human evidence.
How are LL-37 and KPV different?
LL-37 is a 37-residue human cathelicidin studied in host defense and immune signaling. KPV is the three-residue sequence Lys-Pro-Val, derived from the C-terminal region of alpha-melanocyte-stimulating hormone. Their size, origin, experimental models and mechanisms are different.
Is immune modulation always immune stimulation?
No. Immune modulation means altering an immune pathway, and the direction can depend on cell type, tissue, concentration and disease model. Some peptides show pro-inflammatory and anti-inflammatory findings in different contexts. A responsible summary names the model and endpoint instead of using “immune boosting” as a universal claim.
Sources
- PubMed: LL-37 structure and host-defense roles (accessed 2026-08-27)
- PubMed: alpha-MSH and KPV tripeptide review (accessed 2026-08-27)
- PubMed: thymosin alpha-1 review (accessed 2026-08-27)
Research-use notice: This article explains catalog identity and published research. It is not medical advice, a treatment claim or a dosing guide. NOVABIO catalog products are presented for laboratory research and are not represented here as approved for human use.